Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% during the second quarter, Holdings Channel reports. The fund owned 280,319 shares of the medical equipment provider’s stock after selling 13,107 shares during the quarter. Mackenzie Financial Corp’s holdings in Intuitive Surgical were worth $124,700,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ISRG. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth approximately $26,000. Creekmur Asset Management LLC raised its holdings in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. LGT Financial Advisors LLC lifted its position in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the last quarter. Delos Wealth Advisors LLC lifted its holdings in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the last quarter. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical in the first quarter worth $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the completion of the sale, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock worth $25,528,753 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of several research analyst reports. Evercore ISI cut their price objective on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research report on Friday, July 19th. Barclays raised their price objective on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. BTIG Research boosted their price target on Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Finally, Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $446.45.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $479.18 on Friday. The business’s 50-day simple moving average is $473.03 and its 200-day simple moving average is $428.22. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $496.18. The stock has a market capitalization of $169.97 billion, a PE ratio of 86.49, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm’s revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.18 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.